Nicholas Saraceno

At SupplySide Connect New Jersey, BioVivo highlights green tea and green coffee-derived caffeine as a cleaner alternative to synthetic sources, offering smoother energy and stronger appeal in functional beverages.

Live from SupplySide Connect, Megan Olsen, the SVP and general counsel for the CRN highlights growing concerns around DSHEA’s drug preclusion provision, underscoring the need for industry alignment and legislative reform in order to enable industry innovation.

Nutritional Outlook offers a practical guide for industry professionals on multivitamin efficacy, formulation trends, and regulatory considerations.

At SupplySide Connect New Jersey, Megan Olsen, SVP and general counsel of CRN, explains the organization's recent petition to the US Supreme Court to review a recent New York State law regarding supplements violates free speech.

At SupplySide Connect New Jersey, Jim Roza explains how domestic partnerships, seed innovation, and close-to-source manufacturing are shaping more consistent, clinically relevant botanical extracts.

New legislation introduced by Rep. Maxine Dexter aims to establish a federal product registry, drawing mixed reactions from leading industry organizations over implementation and impact.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, describes new findings on Ashwa-30 that highlight how measurable biomarkers can help practitioners tailor protocols for stress, fatigue, and physical strain.

Herbalist & Alchemist introduces a blended mycelium and fruiting body lion’s mane formula, reflecting rising demand for clinically relevant, clean-label nootropics.

At SupplySide Connect New Jersey, Suresh Lakshmikanthan, PhD, Natural Remedies’ chief business officer, explains how dual-standardized Ashwa-30 leverages ATP-active compounds and withanolides to deliver energy, endurance, and metabolic benefits at just 30 mg.

At a SupplySide Connect New Jersey session, industry experts unpack the trends reshaping product development, from protein dominance and fiber innovation, to sustainability, certifications, and shifting consumer trust.

At SupplySide Connect New Jersey, Keely Johnson, Arjuna Natural’s vice president of sales and marketing, discusses new clinical findings on Shoden ashwagandha, including its impact on stress, sleep, and cognitive performance in women ages 30–59.

Latest research on magnesium L-threonate highlights cognitive, sleep, and stress benefits as demand for clinically backed brain health ingredients grows.

At SupplySide Connect New Jersey, Alicia Kasch, RIBUS’ vice president, discusses how Nu-FILL is addressing excipient challenges, and why formulators drive innovation.

At SupplySide Connect New Jersey, Karen Howard, the Organic & Natural Health Association’s CEO and executive director, discusses shifting industry strategy away from fragmented lobbying toward unified, consumer-focused education to drive meaningful regulatory and public health outcomes.

In a sit down with Nutritional Outlook, Brightseed’s Lee Chae explains how the company’s branded platform leverages artificial intelligence and structured biological data to accelerate ingredient discovery, strengthen substantiation, and reduce risk across nutraceutical product development.

Regulatory approval from Brazil’s health authority opens the door for Benicaros to enter a fast-growing supplement market, reinforcing global momentum for clinically validated, sustainable gut health ingredients.

In a chat with Nutritional Outlook, biomedicine professor Mathias Ziegler explores the complexities of NAD+ metabolism, highlighting emerging research on CD38, mitochondrial dynamics, and the gap between biomarker gains and real-world outcomes.

New regulatory clearance for soy protein highlights growing demand for clinically substantiated, plant-based ingredients targeting cardiovascular health.

A new randomized, placebo-controlled study suggests nitrate-rich beetroot extract may support neuromuscular performance and mobility.

A new randomized, placebo-controlled trial suggests that a black seed–derived ingredient may support cortisol balance, endocrine function, and multi-system stress adaptation in moderately stressed adults.

As research expands and new consumer segments emerge, creatine is evolving beyond performance nutrition into cognitive health, healthy aging, and daily wellness applications, bringing new opportunities and challenges for formulators.

The trade association is challenging speech-based restrictions on supplement sales to minors, raising broader questions about First Amendment protections and regulatory precedent in the nutraceutical industry.

Combining clinically studied ingredients with enhanced bioavailability, at Natural Products Expo West, Asha Ramesh, Sabinsa’s CEO – Americas, highlights the growing importance of safety data, regulatory compliance, and full documentation as brands navigate increasing scrutiny in supplement development.

New purpose-built site separates spore and non-spore production, signaling growing demand for clinically positioned biotics and greater emphasis on strain-specific manufacturing.

Women’s health, cognition, GLP-1 support, longevity, and clean-label functional foods are among the key categories influencing demand for clinically substantiated nutraceutical ingredients, notes Asha Ramesh, Sabinsa’s CEO – Americas, from the Expo West floor.

From stress and cognitive support to formulation challenges and regulatory considerations, this FAQ explores the science and market forces shaping ashwagandha’s role in modern nutraceuticals.

New data on USPlus PRO suggest a triple-action benefit for lower urinary tract symptoms, bladder control, and sexual function, highlighting evolving opportunities in men’s health formulations.

Researchers and ingredient suppliers are placing focus on the gut-immune axis and its potential role in digestion, inflammation, immune balance, and year-round wellness support.

In her interview at Natural Products Expo West, Stacey Smith, Gnosis by Lesaffre’s senior medical affairs liaison, discusses how MyCondro’s fermentation-based chondroitin and Quatrefolic’s active folate formats are expanding formulation opportunities across joint health, fertility, healthy aging, and functional delivery systems.

Built on more than a decade of compound research and biological data, the company's new Innovation Platform aims to help health and nutrition companies reduce product development risk and improve commercialization success rates.